<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03693820</url>
  </required_header>
  <id_info>
    <org_study_id>MS.18.09.277</org_study_id>
    <nct_id>NCT03693820</nct_id>
  </id_info>
  <brief_title>Gall Bladder Bed Infiltration Analgesia</brief_title>
  <official_title>The Effect of Gallbladder Bed Infiltration on Analgesia in Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alaa Mazy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Early postoperative pain is a common complaint after elective laparoscopic cholecystectomy.
      Persistent acute postoperative pain is the dominating complaint and the primary reason for a
      prolonged stay after this procedure. This pain can be superficial incisional wound pain
      (somatic), deep visceral pain and/or post-laparoscopy shoulder pain (referred somatic), all
      of which may require systemic analgesia. Hypothesis: Laparoscopic pain can be superficial
      incisional wound pain (somatic pain), deep visceral pain and/or post-laparoscopy shoulder
      pain (referred somatic pain), so the block must be periportal for incisional wound pain,
      intraperitoneal to decrease pain caused by pneumoperitoneum, and of the bladder bed to
      decrease the deep visceral pain. This combination can give the maximum analgesia after
      laparoscopic cholecystectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bladder bed irrigation with Bupivacaine was an effective method for reducing pain during the
      first postoperative hours after laparoscopic cholecystectomy. The intraperitoneal
      administration of lidocaine solution (total dose, 3.5 mg/kg) will be done as follows:
      immediately after creation of the pneumoperitoneum, the surgeon will spray 50-75 ml of the
      total solution on the upper surface of the liver under the right sub-diaphragmatic space, and
      another 50-75ml of the total solution under the left sub-diaphragmatic space. In order to
      allow the sprayed solution to diffuse under the diaphragmatic space, the Trendelenburg
      position will be maintained for 2 minutes.

      In the infiltration group will be administrating 5 ml lidocaine at each port site before
      incision, then the surgeon will spray 50-75 ml of the total solution on the upper surface of
      the liver under the right sub-diaphragmatic space, and another 50-75ml of the total solution
      under the left sub-diaphragmatic space then 50 ml will be infiltrated in the bladder bed
      after clamping of the cystic duct and cystic artery. CO2 will be humidified and wormed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 10, 2018</start_date>
  <completion_date type="Anticipated">September 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>the infiltration cocktail of local anesthetic will be replaced by saline in the same volume.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The total postoperative analgesic consumption</measure>
    <time_frame>postoperative, for 24 hours</time_frame>
    <description>ketorolac and morphine in mg .</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The time to the first request of analgesia</measure>
    <time_frame>postoperative, for 24 hours</time_frame>
    <description>hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The intraoperative fentanyl requirements.</measure>
    <time_frame>intraoperative</time_frame>
    <description>microgram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative pain score: VAS</measure>
    <time_frame>postoperative at 0, 2, 4, 8, 12, 16 and 24 hours</time_frame>
    <description>visual analog score from 0-10, zero is no pain, 10 is the most imaginable pain,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>basal and intraoperatively every 30 minutes, then at 0, 2, 4, 8, 12, 16 and 24 hours post-operatively.</time_frame>
    <description>beat/ minute</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean blood pressure</measure>
    <time_frame>basal and intraoperatively every 30 minutes, then at 0, 2, 4, 8, 12, 16 and 24 hours post-operatively.</time_frame>
    <description>mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of vomiting</measure>
    <time_frame>postoperatively, during the first 24 hours</time_frame>
    <description>number</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the sleep quality</measure>
    <time_frame>postoperatively, after the first night.</time_frame>
    <description>through a score 0-2, where 0= good quite sleep, 1= fair sleep, 2= bad quality of sleep.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction regards analgesia:</measure>
    <time_frame>postoperative after 24 hour.</time_frame>
    <description>using visual analog score from 0-10. zero = no satisfaction, 12= maximum satisfaction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgeon satisfaction regards the technique:</measure>
    <time_frame>postoperative within 1 hour.</time_frame>
    <description>using visual analog score from 0-10. zero = no satisfaction, 10= maximum satisfaction.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Pain, Acute</condition>
  <arm_group>
    <arm_group_label>the infiltration group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>a cocktail of 5 mg/Kg lidocaine normal saline in a volume of 3 ml/Kg 5 mcg/ml adrenaline. We will administrate 5 ml lidocaine at each port site before incision, then immediately after the creation of the pneumoperitoneum, the surgeon will spray 50-75 ml of the total solution on the upper surface of the liver under the right sub-diaphragmatic space and another 50-75ml over the parietal peritoneum. The Trendelenburg position will be maintained for 2 minutes. Then 50 ml will be infiltrated in the bladder bed and pedicle after clamping of the cystic duct and artery. Infiltration will be through a laparoscopic suction needle, diameter 0.9 /330 mm (Zhejiang, China).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>the control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>the same technique but the 50 ml for gallbladder infiltration will be replaced by saline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>the infiltration group</intervention_name>
    <description>15-20 ml periportal,
50 ml in gallbladder bed,
The rest (about 150 ml in 70 Kg patient) will be intraperitoneal</description>
    <arm_group_label>the infiltration group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>the control group</intervention_name>
    <description>the 50 ml prepared for gallbladder bed infiltration will be replaced by saline.</description>
    <arm_group_label>the control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled to undergo elective laparoscopic cholecystectomy.

          -  American Society of Anesthesiologists physical status (ASA) I or II.

        Exclusion Criteria:

          1. Patient in receipt of analgesics or sedatives 24 h before scheduled surgery.

          2. Patient with spillage or cholelithiasis with known common bile duct pathology.

          3. Body Mass Index &gt; 40 Kg/m2.

          4. Patient underlying severe systemic disease.

          5. Patient with a history of abdominal surgery, a chronic pain disorder other than
             gallbladder disease or allergy to lidocaine.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>alaa mazy, MD</last_name>
    <role>Study Director</role>
    <affiliation>faculty of medicine, Mansoura</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>alaa alaa.mazy, MD</last_name>
    <phone>01140065052</phone>
    <email>alaa_mazy@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmed Sadek, MBBCH</last_name>
    <phone>00201003130299</phone>
    <email>dr.storm88@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gastro-enterolgy surgical center, Mansoura University</name>
      <address>
        <city>Mansourah</city>
        <state>Al-Dakahleia</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ahmad M Sadek, MBBCH</last_name>
      <phone>+201003130299</phone>
      <email>dr.storm88@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ahmed M Mahmoud Sadik Mohammed, MBBCH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Monir Othman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alaa Mazy Abdou Mazy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ibrahim Abd Elbasir, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 1, 2018</study_first_submitted>
  <study_first_submitted_qc>October 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 3, 2018</study_first_posted>
  <last_update_submitted>October 2, 2018</last_update_submitted>
  <last_update_submitted_qc>October 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Alaa Mazy</investigator_full_name>
    <investigator_title>associate prosseor</investigator_title>
  </responsible_party>
  <keyword>cholecystectomy;</keyword>
  <keyword>analgesia;</keyword>
  <keyword>gallbladder;</keyword>
  <keyword>infiltration;</keyword>
  <keyword>visceral pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

